Norihito Tarumoto Selected Research

Norihito Tarumoto Research Topics

Disease

13	COVID-19 11/2023 - 01/2020
9	Infections 12/2023 - 01/2014
5	Sepsis (Septicemia) 08/2020 - 12/2014
4	Pneumonia (Pneumonitis) 11/2023 - 12/2021
2	Candidemia 04/2024 - 01/2012
2	Disease Progression 05/2022 - 05/2021
2	Chagas Disease (American Trypanosomiasis) 02/2021 - 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 11/2023
1	Post-Acute COVID-19 Syndrome 11/2023
1	Coinfection 06/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2023
1	Diarrhea 01/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Breakthrough Infections 01/2023
1	Disseminated Intravascular Coagulation 09/2022
1	Inflammation (Inflammations) 09/2022
1	Parkinson Disease (Parkinson's Disease) 09/2022
1	Obesity 12/2021
1	Fever (Fevers) 12/2021
1	Syphilis 12/2020
1	Cholestasis 11/2020
1	Febrile Neutropenia 04/2020
1	Leukemia 04/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Streptococcal Infections (Streptococcal Infection) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Human Influenza (Influenza) 01/2020
1	Shock 01/2020
1	Community-Acquired Infections 01/2018
1	Cryptococcosis 01/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2014
1	Infarction (Infarctions) 01/2012
1	Endocarditis 01/2012
1	Mycoses (Diseases, Fungus) 12/2008
1	Candidiasis (Moniliasis) 12/2008
1	Aspergillosis 12/2008

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2023 - 01/2019
4	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
3	AntigensIBA 08/2023 - 12/2021
3	Immunoglobulin M (IgM)IBA 01/2022 - 01/2020
3	Antifungal AgentsIBA 03/2014 - 12/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 05/2022 - 12/2021
2	Carbapenems (Carbapenem Antibiotics)IBA 08/2020 - 11/2018
2	GlycolipidsIBA 03/2014 - 01/2014
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2023
1	mRNA VaccinesIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	BNT162 VaccineIBA 01/2023
1	polyglucosanIBA 01/2023
1	Nelfinavir (Viracept)FDA Link 01/2023
1	InterleukinsIBA 09/2022
1	Interleukin-17 (Interleukin 17)IBA 09/2022
1	Dacarbazine (DIC)FDA LinkGeneric 09/2022
1	Dopamine (Intropin)FDA LinkGeneric 09/2022
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2022
1	Interleukin-8 (Interleukin 8)IBA 09/2022
1	Peptides (Polypeptides)IBA 09/2022
1	Proteins (Proteins, Gene)FDA Link 09/2022
1	EnzymesIBA 12/2021
1	favipiravirIBA 12/2021
1	Recombinant ProteinsIBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Therapeutic UsesIBA 12/2020
1	MacrolidesIBA 12/2020
1	CoagulaseIBA 11/2020
1	BilirubinIBA 11/2020
1	Guanosine Triphosphate (GTP)IBA 11/2020
1	Imipenem FDA Link 08/2020
1	Anti-Infective Agents (Microbicides)IBA 08/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	16S Ribosomal RNAIBA 08/2019
1	carbapenemaseIBA 11/2018
1	Penicillins (Penicillin)FDA Link 01/2018
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2018
1	Cefotaxime (Kendrick)FDA LinkGeneric 12/2014
1	Interferon-gamma (Interferon, gamma)IBA 03/2014
1	Vancomycin FDA LinkGeneric 01/2012
1	Voriconazole (Vfend)FDA LinkGeneric 12/2008
1	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2008
1	Itraconazole (Sporanox)FDA LinkGeneric 12/2008
1	Flucytosine (Ancobon)FDA Link 12/2008
1	Fluconazole (Zonal)FDA LinkGeneric 12/2008

Therapy/Procedure

4	Therapeutics 04/2024 - 12/2008
2	Extracorporeal Membrane Oxygenation 11/2023 - 01/2020
1	Renal Dialysis (Hemodialysis) 11/2023
1	Aftercare (After-Treatment) 01/2023
1	Mechanical Ventilators (Ventilator) 11/2020
1	Hematopoietic Stem Cell Transplantation 04/2020
1	Cesarean Section (Caesarean Section) 01/2020
1	Length of Stay 11/2018
1	Lasers (Laser) 01/2016
1	Urinary Catheters 12/2014
1	Central Venous Catheters 12/2014